Kovai Medical Center & Hospital Ltd
Kovai Medical Center & Hospital Ltd is a Coimbatore-based company which is in the business of advanced healthcare services. It also forayed into education services in 2019 with the commencement of its new Medical College in Coimbatore.[1]
- Market Cap ₹ 6,405 Cr.
- Current Price ₹ 5,855
- High / Low ₹ 6,725 / 5,010
- Stock P/E 25.0
- Book Value ₹ 1,206
- Dividend Yield 0.26 %
- ROCE 22.6 %
- ROE 20.5 %
- Face Value ₹ 10.0
Pros
- Company has delivered good profit growth of 26.0% CAGR over last 5 years
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Hospital
Part of BSE Healthcare BSE 1000 BSE Hospitals
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 402 | 465 | 531 | 588 | 628 | 712 | 690 | 905 | 1,020 | 1,220 | 1,371 | 1,586 | 1,644 | |
| 307 | 374 | 406 | 459 | 494 | 540 | 495 | 645 | 746 | 874 | 981 | 1,141 | 1,186 | |
| Operating Profit | 94 | 92 | 125 | 129 | 135 | 171 | 195 | 261 | 274 | 346 | 390 | 445 | 458 |
| OPM % | 23% | 20% | 23% | 22% | 21% | 24% | 28% | 29% | 27% | 28% | 28% | 28% | 28% |
| 7 | 8 | 6 | 7 | 8 | 10 | 12 | 12 | 14 | 21 | 21 | 26 | 29 | |
| Interest | 20 | 17 | 15 | 13 | 15 | 18 | 33 | 46 | 43 | 37 | 36 | 36 | 31 |
| Depreciation | 21 | 21 | 24 | 34 | 36 | 52 | 68 | 85 | 89 | 92 | 98 | 109 | 115 |
| Profit before tax | 59 | 62 | 92 | 89 | 93 | 112 | 106 | 141 | 155 | 238 | 278 | 326 | 341 |
| Tax % | 35% | 35% | 35% | 35% | 35% | 15% | 27% | 26% | 25% | 24% | 25% | 25% | |
| 39 | 40 | 60 | 58 | 60 | 95 | 78 | 104 | 116 | 180 | 209 | 244 | 256 | |
| EPS in Rs | 35.37 | 36.95 | 54.81 | 52.99 | 54.96 | 86.44 | 71.00 | 95.28 | 105.80 | 164.25 | 190.96 | 223.41 | 234.24 |
| Dividend Payout % | 4% | 7% | 5% | 6% | 5% | 3% | 4% | 6% | 9% | 6% | 5% | 7% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 18% |
| 3 Years: | 16% |
| TTM: | 15% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 26% |
| 3 Years: | 28% |
| TTM: | 16% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | 29% |
| 3 Years: | 30% |
| 1 Year: | -11% |
| Return on Equity | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 20% |
| 3 Years: | 21% |
| Last Year: | 20% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 |
| Reserves | 127 | 165 | 224 | 276 | 332 | 420 | 499 | 598 | 708 | 878 | 1,075 | 1,308 |
| 163 | 158 | 125 | 202 | 378 | 543 | 623 | 550 | 511 | 310 | 415 | 403 | |
| 85 | 96 | 103 | 116 | 129 | 134 | 148 | 184 | 209 | 240 | 299 | 345 | |
| Total Liabilities | 386 | 430 | 464 | 605 | 850 | 1,108 | 1,281 | 1,343 | 1,439 | 1,439 | 1,801 | 2,067 |
| 281 | 337 | 354 | 443 | 469 | 643 | 1,033 | 1,085 | 1,088 | 1,118 | 1,283 | 1,474 | |
| CWIP | 17 | 10 | 6 | 13 | 227 | 300 | 45 | 5 | 23 | 39 | 154 | 135 |
| Investments | 4 | 4 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 85 | 78 | 100 | 149 | 153 | 165 | 203 | 253 | 328 | 282 | 364 | 458 | |
| Total Assets | 386 | 430 | 464 | 605 | 850 | 1,108 | 1,281 | 1,343 | 1,439 | 1,439 | 1,801 | 2,067 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 97 | 85 | 99 | 87 | 126 | 166 | 186 | 262 | 263 | 344 | 335 | 362 | |
| -80 | -113 | -83 | -192 | -352 | -349 | -180 | -292 | -358 | -290 | -593 | -514 | |
| -43 | -24 | -50 | 60 | 160 | 113 | 38 | -119 | -86 | -243 | 62 | -58 | |
| Net Cash Flow | -26 | -53 | -33 | -45 | -66 | -70 | 44 | -149 | -180 | -189 | -197 | -210 |
| Free Cash Flow | 60 | 14 | 63 | -41 | -151 | -102 | 5 | 163 | 136 | 206 | -18 | 111 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 119% | 109% | 99% | 92% | 117% | 115% | 106% | 115% | 110% | 116% | 101% | 100% |
Ratios
Standalone / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 9 | 7 | 8 | 8 | 6 | 4 | 7 | 8 | 8 | 5 | 8 | 9 |
| Inventory Days | 25 | 22 | 20 | 23 | 20 | 23 | 19 | 19 | 18 | 17 | 15 | 17 |
| Days Payable | 53 | 47 | 37 | 43 | 47 | 46 | 29 | 20 | 35 | 30 | 27 | 20 |
| Cash Conversion Cycle | -19 | -19 | -9 | -12 | -21 | -19 | -2 | 6 | -9 | -7 | -4 | 6 |
| Working Capital Days | -60 | -56 | -50 | -48 | -55 | -39 | -56 | -49 | -48 | -49 | -57 | -58 |
| ROCE % | 27% | 25% | 31% | 24% | 18% | 15% | 13% | 16% | 17% | 23% | 23% | 23% |
Insights
In beta| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Average Length of Stay Days |
|
|||||||
| Average Revenue per Occupied Bed (ARPOB) INR |
||||||||
| Bed Capacity Nos. |
||||||||
| Bed Occupancy Rate % |
||||||||
| Inpatient Volume Nos. |
||||||||
| Outpatient Volume Nos. |
||||||||
| Medical College (KMCH IHSR) Students Nos. |
||||||||
Extracted by Screener AI
Documents
Announcements
-
Board Meeting Intimation for Considering The Un-Audited Financial Results For The Quarter/Half Year Ended 30.09.2026.
- Board meeting on 11 November 2026 to consider Q2/H1 FY2026-27 unaudited results.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- We enclose herewith the copies of Newspaper Advertisement published in English and Tamil on 10th October,2026 in the "Trinity Mirror" and "Makkal Kural" respectively, with …
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Submitted Regulation 74(5) certificate for quarter ended 30 September 2026; 30 share certificates dematerialised.
- Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
- Closure of Trading Window
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from bse
-
Annual Report 2012
from bse
Business Segments